Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment.

导出 LinkOut

翻译打印收藏纠错

作者： Riccardo,Garbo ^[1] ; Simone,Lorenzut ^[2] ; Ilaria,Del Negro ^[3] ; Giovanni,Merlino ^[3] ; Gian Luigi,Gigli ^[4] ; Daniela,Cargnelutti ^[2] ; Mariarosaria,Valente ^[5]

作者单位： Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy. Electronic address: riccardo.garbo@outlook.it. ^[1] Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy. ^[2] Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy. ^[3] Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy; Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100, Udine, Italy; Department of Mathematics, Informatics and Physics (DMIF), University of Udine, Via delle scienze 206, 33100, Udine, Italy. ^[4] Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy; Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100, Udine, Italy. ^[5]

关键词 Dimethyl fumarate Lymphocyte count Lymphopenia Multiple sclerosis Risk factors Treatment response